The role of vitamin D receptor activation in chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Dialysis patients exhibit significantly higher cardiovascular disease (CVD) mortality rates compared to the general population.
• Progressive renal dysfunction in chronic kidney disease (CKD) is closely linked to CVD and mortality.
• Vitamin D receptor (VDR) activation deficiencies are implicated in adverse cardiovascular health and secondary hyperparathyroidism (SHPT) in CKD.

Purpose of the Study:

• To explore the role of VDR activation in cardiovascular health among CKD patients.
• To review the impact of VDR modulation on mineral metabolism and vascular calcification.
• To assess the potential benefits of selective VDR activators in managing SHPT and reducing CVD risk.

Main Methods:

• Review of observational data linking renal dysfunction, CVD, and mortality.
• Analysis of evidence on VDR expression and function in mineral metabolism and cardiovascular health.
• Evaluation of recent advancements in SHPT management, including selective VDR activators.

Main Results:

• VDR activation plays a key role in cardiovascular health and mineral metabolism homeostasis.
• Selective VDR activators may reduce parathyroid hormone levels, minimizing hypercalcemia and hyperphosphatemia risks.
• These agents show potential for improving overall patient health and reducing CVD risk in CKD.

Conclusions:

• VDR activation is critical for cardiovascular health in CKD patients.
• Selective VDR activators offer a promising therapeutic strategy for SHPT management.
• Targeting VDR activation can mitigate CVD risks and improve outcomes for dialysis patients.